Lataa...
The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
HCV represents a global health problem with ~200 million individuals currently infected, worldwide. With the high cost of antiviral therapies, the global burden of chronic hepatitis C infection (CHCV) infection will be substantially reduced by the development of an effective vaccine for HCV. The fie...
Tallennettuna:
| Julkaisussa: | Front Microbiol |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5674006/ https://ncbi.nlm.nih.gov/pubmed/29163442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2017.02163 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|